The COVID-19 pandemic served as a catalyst for the rapid adoption of telehealth services across the United States. As in-person...
Read moreA Comprehensive Guide to Tapering GLP-1 Medications Without Regaining Weight
Read moreIntroduction: How January Sets the Tone for 2025 in Healthcare Every year, the first month sets a precedent for where...
Read moreImmigration policies in the United States have historically been intertwined with public health concerns, particularly regarding the transmission of communicable...
Read moreThe Department of Justice alleges that Dr. Haim leaked patient information to expose the hospital's performing gender-affirming care.
Read moreHealth journalists perceive artificial intelligence (AI) as a valuable instrument to augment their journalistic endeavors.
Read moreAlthough colorectal cancer is the second-most common cause of cancer deaths in the United States, it can be cured if...
Read moreDespite about twenty percent of people appearing to have a genetic predisposition to opiate addiction, this only accounts for 40...
Read moreAccording to the Association of Healthcare Journalists, more members are now freelance journalists than employed journalists.
Read moreAre you ready to transform your health and elevate your life to new heights? The key lies in establishing daily...
Read moreWhile the idea of ticks may seem harmless, they can carry a number of diseases and allergens that can be...
Read moreRoughly 1 in 5 U.S. adults report binge drinking at least once a week, with an average of seven drinks...
Read moreGlucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy